Pharmaceutical Special Interest Group Autumn Meeting- 5^th November 2008

AstraZeneca, Charnwood.

All delegates registered by 13:00 on 31/10/08 have been sent an E-mail confirmation with joining instructions.
These joining instructions have now been added to the Travel Directions page under the heading - "On arrival at the venue".

Sorry, Registration is now closed!
Please contact the local organiser Talbir Austin (see foot of page) if you have any queries about local meeting arrangements.
Contact David Beveridge regarding meeting fees.

View a printer friendly PDF (38kb)Programme & Abstract document.

Travel Directions Page.

Pharmaceutical SIG - 5^th November 2008

Programme.

Programme chairs: Anne Kavanagh, Brett Cooper and Matthew Johnson. contact details...

From 09:00 Registration & Coffee.

Morning Session, Chair: Matthew Johnson (GlaxoSmithKline)

09:45 Talbir Austin, AstraZeneca:
Opening Remarks and Safety.

10:00 Robert Docherty, Pfizer:
The Future Application of Computational Methods in Solid Form Selection.

10:45 Graeme Day, University of Cambridge:
Discovering and Understanding New Crystal Forms: Guiding Experiments by Crystal Structure Prediction and Modelling

11:15 Refreshments

11:45 Frank Leusen, University of Bradford:
A Major Advance in Crystal Structure Prediction

12:15 Xue Wang, University of Leeds:
Crystal Morphology: Measurement, Modelling and Closed-loop Control

12:45 Lunch

Afternoon Session. Chair: Brett Cooper (Merck Sharp & Dohme)

14:00 Amy Robertson, AstraZeneca:
Process Analytical Technology Applications in Crystallisation Development

14:30 Claire Thompson, GlaxoSmithKline:
Pharmaceuticals in a State of Disorder - But How Much?

15:00 Refreshments

15:30 Matt Tucker, ISIS:
Looking Beyond the Bragg Peaks with Total Scattering

16:00 Anne Kavanagh, BCA Industrial Group Chair:
Closing Remarks.

16:15 Close

Local organiser:
Dr Talbir Austin
Tel: 01509 645236
Email: talbir.austin@astrazeneca.com